| Daelynn Jo Smith, FNP | |
|
1404 Pomerelle Ave, Suite B, Burley, ID 83318-2012 | |
| (208) 878-9432 | |
| (208) 878-4576 |
| Full Name | Daelynn Jo Smith |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 9 Years |
| Location | 1404 Pomerelle Ave, Burley, Idaho |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265891261 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | NP-1705A (Idaho) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lost Rivers Medical Center | Arco, ID | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Anthony J Anderson Md And Assoc Llc | 5597064709 | 3 |
News Archive
Investigators at Washington University School of Medicine in St. Louis have found that cells making up a non-visual system in the eye are in place and functioning long before the rods and cones that process light into vision.
The Smart Choices Program announced today that it will voluntarily postpone active operations and not encourage wider use of the logo at this time by either new or currently enrolled companies.
Scientists at the University of Basel discovered a fundamental new mechanism explaining the inadequate immune defense against chronic viral infection. These results may open up new avenues for vaccine development. They have been published in the journal "Science Immunology".
Protox Therapeutics Inc., a leader in the development of receptor targeted fusion proteins, today announced positive six month data from its double-blind placebo controlled Phase 2b study of PRX302 (study name: TRIUMPH) in patients with moderate to severe benign prostatic hyperplasia (BPH) a bothersome urologic condition that affects the quality of life of more than 50 million men worldwide.
› Verified 3 days ago
| Entity Name | Anthony J Anderson Md & Assoc Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558604231 PECOS PAC ID: 5597064709 Enrollment ID: O20160421002366 |
News Archive
Investigators at Washington University School of Medicine in St. Louis have found that cells making up a non-visual system in the eye are in place and functioning long before the rods and cones that process light into vision.
The Smart Choices Program announced today that it will voluntarily postpone active operations and not encourage wider use of the logo at this time by either new or currently enrolled companies.
Scientists at the University of Basel discovered a fundamental new mechanism explaining the inadequate immune defense against chronic viral infection. These results may open up new avenues for vaccine development. They have been published in the journal "Science Immunology".
Protox Therapeutics Inc., a leader in the development of receptor targeted fusion proteins, today announced positive six month data from its double-blind placebo controlled Phase 2b study of PRX302 (study name: TRIUMPH) in patients with moderate to severe benign prostatic hyperplasia (BPH) a bothersome urologic condition that affects the quality of life of more than 50 million men worldwide.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Daelynn Jo Smith, FNP 1404 Pomerelle Ave, Suite B, Burley, ID 83318-2012 Ph: (208) 878-9432 | Daelynn Jo Smith, FNP 1404 Pomerelle Ave, Suite B, Burley, ID 83318-2012 Ph: (208) 878-9432 |
News Archive
Investigators at Washington University School of Medicine in St. Louis have found that cells making up a non-visual system in the eye are in place and functioning long before the rods and cones that process light into vision.
The Smart Choices Program announced today that it will voluntarily postpone active operations and not encourage wider use of the logo at this time by either new or currently enrolled companies.
Scientists at the University of Basel discovered a fundamental new mechanism explaining the inadequate immune defense against chronic viral infection. These results may open up new avenues for vaccine development. They have been published in the journal "Science Immunology".
Protox Therapeutics Inc., a leader in the development of receptor targeted fusion proteins, today announced positive six month data from its double-blind placebo controlled Phase 2b study of PRX302 (study name: TRIUMPH) in patients with moderate to severe benign prostatic hyperplasia (BPH) a bothersome urologic condition that affects the quality of life of more than 50 million men worldwide.
› Verified 3 days ago
Shaylynn Sherrick Smith, FNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2303 Park Ave, Burley, ID 83318 Phone: 208-677-3073 | |
Amy Lou Jensen, FNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1404 Pomerelle Ave Ste A1, Burley, ID 83318 Phone: 208-878-8783 Fax: 208-878-8786 | |
Ms. Ann Cueva, RNCFNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1252 Bennett Ave, Suite B, Burley, ID 83318 Phone: 208-878-3486 Fax: 208-878-2005 | |
Mr. Scott Michael Cook, APRN-CNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1501 Hiland Ave, Burley, ID 83318 Phone: 208-678-4444 | |
Cindy Hurst, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1700 Overland Ave, Burley, ID 83318 Phone: 208-825-6193 Fax: 208-825-6199 | |
Lyndsie Chatburn, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1309 Bennett Ave, Burley, ID 83318 Phone: 208-678-7796 Fax: 208-678-7799 |